The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Belov Yu.V.

RNTsKh im. akad. B.V. Petrovskogo RAMN

Vinokurov I.A.

FGBU "Rossiĭskiĭ nauchnyĭ tsentr khirurgii im. akad. B.V. Petrovskogo" RAMN, Moskva

Bogopol'skaia O.M.

FGBU RNTsKh im. akad. B.V. Petrovskogo RAMN, Moskva

Komarov R.N.

Clinic for Aortic and Cardiovascular Surgery, I.M. Sechenov First Moscow State Medical University

Biomarkers in differential diagnostics of acute coronary and aortic syndromes

Authors:

Belov Yu.V., Vinokurov I.A., Bogopol'skaia O.M., Komarov R.N.

More about the authors

Read: 2778 times


To cite this article:

Belov YuV, Vinokurov IA, Bogopol'skaia OM, Komarov RN. Biomarkers in differential diagnostics of acute coronary and aortic syndromes. Russian Journal of Cardiology and Cardiovascular Surgery. 2012;5(3):44‑47. (In Russ.)

Recommended articles:
Difficulties in life­time diagnosis of Creutzfeldt—Jakob disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11):19-27
Clinical case of auri­cular gouty tophi. Russian Bulletin of Otorhinolaryngology. 2024;(6):80-84
Obstructive sleep apnea syndrome as a predictor of atrial fibrillation. Russian Journal of Preventive Medi­cine. 2025;(1):109-114
Methemoglobinemia with symptoms of acute coro­nary syndrome. Russian Journal of Anesthesiology and Reanimatology. 2025;(1):101-108

References:

  1. Amosova E.N. Metabolicheskaya terapiya povrezhdeniya miokarda, obuslovlennogo ishemiei: novyi podkhod k lecheniyu ishemicheskoi bolezni serdtsa i serdechnoi nedostatochnosti. Ukr kardіol zhurn 2000; 4: 85-92.
  2. Lishnevskaya V.Yu. Metabolicheskaya terapiya pri IBS - iz proshlogo v budushchee. Consilium Medicum Ukraina 2008; 1: 34-39.
  3. Trifonov I.R. Biokhimicheskie markery nekroza miokarda. Chast' 1. Obshchaya kharakteristika biomarkerov. Ikh primenenie dlya diagnostiki infarkta miokarda: obzor sovremennykh rekomendatsii. Kardiologiya 2001; 1: 93-95.
  4. Aikawa M., Sivam P.N., Kuro-o M. et al. Human smooth muscle myosin heavy chain isoforms as molecular markers for vascular development and atherosclerosis. Circ Res 1993; 73: 1000-1012.
  5. Armstrong E.J., Morrow D.A., Sabatine M.S. Inflammatory Biomarkers in Acute Coronary Syndromes: Part II: Acute-Phase Reactants and Biomarkers of Endothelial Cell Activation. Circulation 2006; 113: e152-e155.
  6. Boyum J., Fellinger E.K., Schimoker J.D. et al. Matrix metalloproteinase activity in thoracic aortic aneurysms associated with bicuspid and tricuspid aortic valves. J Thorac Cardiovasc Surg 2004; 127: 686-691.
  7. Blankenberg S., Rupprecht H.J., Poirier O. et al. Plasma Concentrations and Genetic Variation of Matrix Metalloproteinase 9 and Prognosis of Patients With Cardiovascular Disease. Circulation 2003; 107: 1579-1585.
  8. de Lemos J.A., Morrow D.A., Gibson C.M. et al. The prognostic value of serum myoglobin in patients with non-ST-segment elevation acute coronary syndromes. Results from the TIMI 11B and TACTICS-TIMI 18 studies. J Am Coll Cardiol 2002; 40: 2: 238-244.
  9. Erbel R., Alfonso F., Boileau C. et al. Diagnosis and management of aortic dissection. Eur Heart J 2001; 22: 1642-1681.
  10. Ibanez J.I., Sobrado R., Rivero M. et al. Use of troponin-I, CPK-MB and myoglobin in the diagnosis of myocardial infarct and processesof muscular necrosis of non-cardiac origin. An Syst Sanit Navar 2001; 24: 1: 15-23.
  11. Jaffe A.S., Ravkilde J., Roberts R. et al. It's time for a change to a troponin standard. Circulation 2000; 102: 11: 1216-1220.
  12. Katoh H., Suzuki T., Yokomori K. et al. A novel immunoassay of smooth muscle myocin heavy chain in serum. J Immunol Methods 1995; 185: 57-63.
  13. Khan I., Nair C. Clinical, Diagnostic, and Management Perspectives of aortic Dissection. Chest 2002; 122: 311-328.
  14. Kuro-o M., Nagai R., Tsuchimochi H. et al. Developmentally regulated expression of vascular smooth muscle myosin heave chain isoforms. J Biol Chem 1989; 264: 18272-18275.
  15. MacRae A.R., Kavsak P.A., Lustig V. et al. Assessing the Requirement for the 6-Hour Interval between Specimens in the American Heart Association Classification of Myocardial Infarction in Epidemiology and Clinical Research Studies. Clin Chem 2006; 52: 812-818.
  16. Meszaros I., Morocz J., Szlavi J. et al. Epidemiology and clinicopathology of aortic dissection. Chest 2000; 117: 1271-1278.
  17. Myers G.L., Rifai N., Rifai N.F. et al. CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: report from the laboratory science discussion group. Circulation 2004; 110: e543-e544.
  18. Pepin M., Schwarze U., Superti-Furga A. et al. Clinical and genetic features of Ehlers-Danlos syndrome type IV, the vascular type. N Engl J Med 2000; 342: 673-680.
  19. Powell J.T., Vine N., Crossman M. On the accumulation of D-aspartate in elastin and other proteins of the ageing aorta. Atherosclerosis 1992; 97: 201-208.
  20. Plebani M., Zaninotto M. Diagnostic strategies using myoglobin measurement in myocardial infarction. Clin Chim Acta 1998; 27: 269-277.
  21. Rader D.J. Inflammatory Markers of Coronary Risk. N Engl J Med 2000; 343: 1179-1182.
  22. Katayama M., Handa M., Ambo H. et al. A monoclonal antibody-based enzyme immunoassay for human GMP-140/P-selectin. J Immunol Methods 1992; 153: 41-48.
  23. Rucker R.B., Tinker D. Structure and metabolism of arterial elastin. Int Rev Exp Pathol 1977; 17: 1-47.
  24. Shinohara T., Suzuki K., Okada M. et al. Soluble elastin fragments in serum are elevated in acute aortic dissection. Ateroscler Thromb Vasc Biol 2003; 23: 1839-1844.
  25. Schillinger M., Domanovits H., Bayegan K. et al. C-reactive protein and mortality in patients with acute aortic disease. Intensive Care Med 2002; 28: 740-745.
  26. Sundt T.M., Mora B.N., Moon M.R. et al. Options for repair of a bicuspid aortic valve and ascending aortic aneurysm. Ann Thorac Surg 2000; 69: 133.
  27. Suzuki T., Katoh H., Tsuchio Y. et al. Diagnostic implications of elevated levels of smooth-muscle myocin heavy-chain protein in acute aortic dissection: the smooth muscle myocin heavy chain study. Ann Intern Med 2000; 133: 537-541.
  28. Suzuki T., Katoh H., Watanabe M. et al. Novel biochemical diagnostic method for aortic dissection: results of a prospective study using immunoassay of smooth muscle myocin heavy chain. Circulation 1996; 93: 1244-1249.
  29. Suzuki T., Katoh H., Nagai R. Biochemical Diagnosis of Aortic Dissection: from Bench to Bedside. Jpn Heart J 1999; 40: 5: 527-534.
  30. Tanasijevic J.M. Non-invasive assessment of coronary artery patency after thrombolysis using serum myoglobin measurements. Prilozi 2007; 28: 1: 5-11.
  31. van der Loo B., Jenni R. Acute aortic syndrome proposal for a novel classification. Heart 2003; 89: 928.
  32. Vilacosta I. Acute aortic syndrome. Heart 2003; 85: 365-368.
  33. Verma S., Szmitko P.E., Ridker P.M. C-reactive protein comes of age. Nat Clin Pract 2005; 2: 29-36.
  34. Vilacosta I. Acute aortic syndrome. Heart 2001; 85: 365-368.
  35. von Kodolotsch Y., Schwarts A.G., Nienaber C.A. Clinical prediction of acute aortic dissection. Arch Int Med 2000; 160: 2977-2982.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.